FogPharma Stock
HealthTechLooking to sell FogPharma stock or options?
FogPharma specializes in creating cell-penetrating mini proteins (CPMPs) aimed at targeting and neutralizing cancer-causing proteins within cancer cells. These CPMPs represent a groundbreaking class of medicines capable of reaching drug targets that conventional therapies cannot address, allowing physicians to effectively treat diseases related to cancer.
Alex Gorsky, Marshall Wace, Deerfield Management, Cormorant Asset Management, Horizons Ventures, WuXi AppTec, SymBiosis Capital Management, T. Rowe Price Group, HBM Healthcare Investments, RA Capital Management, The Invus Group, GV, Blue Pool Capital, Foresite Capital, Samsara BioCapital, General Catalyst, PagsGroup, Pivotal Life Sciences, Casdin Capital, Leerink Partners, Fidelity Management & Research, HBM Partners, Rock Springs Capital, venBio, 6 Dimensions Capital.